FDA.reportPublic FDA data

cysteamine 4.4 MG/ML Ophthalmic Solution

RxCUI
1313780
RxNorm name
cysteamine 4.4 MG/ML Ophthalmic Solution
Display name
cysteamine 4.4 MG/ML Ophthalmic Solution
Full name
cysteamine 4.4 MG/ML Ophthalmic Solution
Term type
SCD
Status
DailyMed mapping
Updated
2026-06-04 23:39:18

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
CYSTARANCYSTEAMINE HYDROCHLORIDELeadiant Biosciences, Inc.b98ee838-ed23-42a9-93b5-72579e490fba2025-04-30Warnings, Adverse reactionsExact identifier
rxcui: 1313780

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
b98ee838-ed23-42a9-93b5-72579e490fbacysteamine HCl 0.44 % Ophthalmic Solution [PSN] · cysteamine 4.4 MG/ML Ophthalmic Solution [SCD] · cysteamine 0.44 % Ophthalmic Solution [SY] · cysteamine 4.4 MG/ML (as cysteamine hydrochloride 6.5 MG/ML) Ophthalmic Solution [SY]423These highlights do not include all the information needed to use CYSTARAN ® safely and effectively. See full prescribing information for CYSTARAN. CYSTARAN (cysteamine ophthalmic solution) 0.44%, for topical ophthalmic use Initial U.S. Approval: 199420250430